News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sprout Pharma Takes Root Raising $5 Million for Sexual Dysfunction Drug



4/4/2012 7:11:56 AM

Could a female Viagra be developed? Sprout Pharmaceuticals wants to find out if it can make a so-called pink Viagra and it’s picking up where German pharmaceutical company Boehringer Ingelheim left off. Sprout acquired flibanserin, a compound that Boehringer pursued as a drug to treat hypoactive sexual desire disorder, or HSDD — essentially, diminished sexual desire. Sprout has now raised $5 million to support the Raleigh, North Carolina company’s efforts to commercialize a product to treat this female sexual dysfunction.

Read at News Release


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES